Review Article
Interleukin-17 Gene Polymorphisms Contribute to Cancer Risk
Table 1
Characteristics of case-control studies on IL-17A rs2275913G>A and IL-17F rs763780 T>C polymorphisms and cancer risk included in the meta-analysis.
| First author | Year | Country | Ethnicity | Source of controls | Case | Control | Genotype distribution | P for HWEa |
MAF |
Genotyping method |
Cancer category | Case | Control | G/G | G/A | A/A | G/G | G/A | A/A |
| Zhang [20] |
2014 | China | Asian | Population controls | 260 | 512 | 110 | 102 | 48 | 258 | 187 | 67 | <0.01 | 0.31 | MassARRAY | Gastric cancer | Zhou [21] |
2013 | China | Asian | Hospital controls | 301 | 446 | 79 | 154 | 68 | 164 | 204 | 78 | 0.29 | 0.40 | TaqMan | Bladder cancer | Zhu [22] |
2014 | China | Asian | Hospital controls | 293 | 550 | 126 | 122 | 45 | 273 | 216 | 61 | 0.07 | 0.31 | MassARRAY | Gastric cancer | Rafiei [23] | 2013 | Iran | Caucasian | Healthy controls | 161 | 171 | 56 | 61 | 44 | 78 | 72 | 21 | 0.49 | 0.33 | PCR-RFLP | Gastric cancer | Quan [24] | 2012 | China | Asian | Hospital controls | 311 | 463 | 93 | 142 | 76 | 168 | 215 | 80 | 0.43 | 0.40 | TaqMan | Cervical cancer | Arisawa [25] | 2012 | Japan | Asian | Hospital controls | 333 | 583 | 112 | 137 | 84 | 218 | 293 | 72 | 0.08 | 0.37 | PCR-SSCP | Gastric cancer | Wang [26] | 2012 | China | Asian | Population controls | 491 | 501 | 165 | 234 | 92 | 198 | 245 | 58 | 0.17 | 0.36 | SNaPshot SNP assay | Breast cancer | Wu [27] | 2010 | China | Asian | Population controls | 945 | 768 | 210 | 485 | 250 | 193 | 371 | 204 | 0.35 | 0.51 | PCR-RFLP | Gastric cancer | Chen [28] |
2010 | China | Asian | Population controls | 1042 | 1090 | 300 | 522 | 220 | 325 | 541 | 224 | 0.97 | 0.45 | TaqMan | Gastric cancer | Shibata [15] | 2009 | Japan | Asian | Hospital controls | 287 | 523 | 94 | 124 | 69 | 175 | 299 | 49 | <0.01 | 0.38 | PCR-SSCP | Gastric cancer |
| | | | | | | | T/T | T/C | C/C | T/T | T/C | C/C | | | | |
| Zhang [20] | 2014 | China | Asian | Population controls | 260 | 512 | 209 | 30 | 21 | 429 | 53 | 30 | <0.01 | 0.11 | MassARRAY | Gastric cancer | Zhou [21] | 2013 | China | Asian | Hospital controls | 301 | 446 | 240 | 57 | 4 | 317 | 124 | 5 | 0.06 | 0.15 | TaqMan | Bladder cancer | Zhu [22] | 2014 | China | Asian | Hospital controls | 293 | 550 | 241 | 35 | 17 | 463 | 58 | 29 | <0.01 | 0.11 | MassARRAY | Gastric cancer | Quan [24] | 2012 | China | Asian | Hospital controls | 311 | 462 | 222 | 85 | 4 | 332 | 126 | 5 | 0.06 | 0.15 | TaqMan | Cervical cancer | Wang [26] | 2012 | China | Asian | Population controls | 491 | 502 | 382 | 103 | 6 | 396 | 99 | 7 | 0.77 | 0.11 | SNaPshot SNP assay | Breast cancer | Wu [27] | 2010 | China | Asian | Population controls | 927 | 777 | 540 | 332 | 55 | 527 | 214 | 36 | 0.02 | 0.18 | PCR-RFLP | Gastric cancer | Shibata [15] | 2009 | Japan | Asian | Hospital controls | 280 | 523 | 221 | 55 | 4 | 419 | 100 | 4 | 0.46 | 0.10 | PCR-SSCP | Gastric cancer |
|
|
HWE in control. MAF: minor allele frequency in control group.
|